California state regulators ordered Anthem Blue Cross Blue Shield late last week to pay providers for outstanding claims owed during the last four years. However, Anthem is pushing back and might not comply with the order.
.
The California Department of Managed Healthcare (DMHC) identified errors in claims that Anthem processed since 2007, prompting it to demand the state's largest for-profit insurer pay the outstanding amounts it owes doctors and hospitals, reported the Sacramento Business Journal
Anthem, though, says it already settled the outstanding claims with DMHC when it paid a $500,000 administrative fine as part of a settlement agreement last year.
The settlement was a result of DMHC's claims audits in 2008 after providers complained of insurers' late and inaccurate payments and inappropriate claims denials. DMHC ordered several insurers, including Anthem, to pay providers, improve their claims processes, sign settlement agreements and pay administrative fines. All insurers involved have begun paying the outstanding claims except Anthem, noted the SBJ.
Read the full story at: http://tinyurl.com/7rooa8g
Source: FierceHealthPayer
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More